drugset / Trial / NCT04906434
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
NaSequentialOpen-labelTreatment
Summary
This is an open-label phase 1 study with an escalation part and an expansion part.
Timeline
- Start
- 2020-02-26
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABSK-011 | Unknown | — | Oral |